Pfizer Inc. is voluntarily recalling approximately 20,729 bottles of Accupril (quinapril HCl) tablets used to treat high blood pressure. This recall affects the 10 mg, 20 mg, and 40 mg strengths of the medication sold in 90-count bottles. The tablets were found to contain levels of N-nitrosoquinapril, a probable carcinogen, above acceptable safety limits. No injuries or illnesses have been reported to date, and the company is taking this action as a precaution.
The tablets may contain N-nitrosoquinapril, which is a type of nitrosamine. These impurities are classified as probable human carcinogens, meaning that long-term exposure to levels above acceptable limits may increase the risk of developing cancer.
You have 2 options:
Recall #: D-0872-2022
Recall #: D-0873-2022
Recall #: D-0874-2022
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.